Solid organ transplantation in HIV-infected recipients

Pediatric Transplantation

Volumn 8, Issue 3, 2004, Pages 214-221

  El Sayegh, Suzanne ^a   Keller, Marla J ^a   Huprikar, Shirish ^a   Murphy, Barbara ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

HAART; HIV; Kidney; Liver; Transplantation

Indexed keywords

COMORBIDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

HEALTH CARE AND PUBLIC HEALTH;

AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION;

EID: 2942754008     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2004.00190.x     Document Type: Review

References (62)

1. SPITAL A. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers. Transplantation 1998: 65: 1187-1191.
2. JONES JL, HANSON DL, DWORKIN MS, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 1999: 48: 1-22.
3. KIMMEL PL, BARISONI L, KOPP JB. Pathogenesis and treatment of HIV-associated renal diseases: Lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003: 139: 214-226.
4. Ross MJ, KLOTMAN PE. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 2002: 13: 2997-3004.
5. NOCHY D, GLOTZ D, DOSQUET P, et al. Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 1993: 8: 11-19.
6. CASANOVA S, MAZZUCCO G, BARBIANO DI BELGIOJOSO G, et al. Pattern of glomerular involvement in human immunodeficiency virus-infected patients: An Italian study. Am J Kidney Dis 1995: 26: 446-453.
7. RAO TK. Human immunodeficiency virus infection and renal failure. Infect Dis Clin North Am 2001: 15: 833-850.
8. WALI RK, DRACHENBERG CI, PAPADIMITRIOU JC, KEAY S, RAMOS E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998: 352: 783-784.
9. WINSTON JA, BRUGGEMAN LA, ROSS MD, et al. Nephropathy and establishment of a renal reservoir of HIV type I during primary infection. N Engl J Med 2001: 344: 1979-1984.
10. SAULSBURY F. Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy. Clin Infect Dis 2001: 32: 464-468.
11. VIANI RM, DANKNER WM, MUELENAER PA, SPECTOR SA. Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube. Pediatrics 1999: 104: 1394-1396.
12. PARDO V, MENESES R, OSSA L, et al. AIDS-related glomerulopathy: Occurrence in specific risk groups. Kidney Int 1987: 31: 1167-1173.
13. AHUJA TS, GRADY J, KHAN S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002: 13: 1889-1893.
14. DUMMER JS, ERB S, BREINIG MK, et al. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989: 47: 134-140.
15. ERICE A, RHAME FS, HEUSSNER RC, DUNN DL, BALFOUR HH, Jr. Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review. Rev Infect Dis 1991: 13: 537-547.
16. SCHWARZ A, OFFERMANN G, KELLER F, et al. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation - Data on four cases and review of the literature. Transplantation 1993: 55: 95-103.
17. TZAKIS AG, COOPER MH, DUMMER JS, RAGNI M, WARD JW, STARZL TE. Transplantation in HIV+ patients. Transplantation 1990: 49: 354-358.
18. MURPHY B. Renal transplantation in HIV-infected recipients: Twenty three cases in the HAART-era. J Am Soc Nephrol 2002: 13: 11a.
19. SHEPPARD HW, ASCHER MS. The natural history and pathogenesis of HIV infection. Annu Rev Microbiol 1992: 46: 533-564.
20. KARON JM, ROSENBERG PS, McQUILLAN G, KHARE M, GWINN M, PETERSEN LR. Prevalence of HIV infection in the United States, 1984 to 1992. J Am Med Assoc 1996: 276: 126-131.
21. OCKENGA J, TILLMANN HL, TRAUTWEIN C, STOLL M, MANNS MP, SCHMIDT RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997: 27: 18-24.
22. BESSESEN M, IVES D, CONDREAY L, LAWRENCE S, SHERMAN KE. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis 1999: 28: 1032-1035.
23. SULKOWSKI MS, THOMAS DL. Hepatitis C in the HIV-infected patient. Clin Liver Dis 2003: 7: 179-194.
24. EYSTER ME, DIAMONDSTONE LS, LIEN JM, EHMANN WC, QUAN S, GOEDERT JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1993: 6: 602-610.
25. BENHAMOU Y, BOCHET M, DI MARTINO V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999: 30: 1054-1058.
26. PRACHALIAS AA, POZNIAK A, TAYLOR C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001: 72: 1684-1688.
27. OSMOND DH, CHARLEBOIS E, SHEPPARD HW, et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993: 167: 66-71.
28. SORIANO V, GARCIA-SAMANIEGO J, RODRIGUEZ-ROSADO R, GONZALEZ J, PEDREIRA J. Hepatitis C and HIV infection: Biological, clinical, and therapeutic implications. J Hepatol 1999: 31(Suppl.1): 119-123.
29. BICA I, McGOVERN B, DHAR R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001: 32: 492-497.
30. SAMUEL D, CASTAING D, ADAM R, et al. Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft. Lancet 1988: 1: 1221-1222.
31. SHAFFER D, PEARL RH, JENKINS RL, et al. HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc 1987: 19: 2176-2178.
32. RAGNI MV, BONTEMPO FA, LEWIS JH. Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med 1990: 322: 1886-1887.
33. JACOBSON SK, CALNE RY, WREGHITT TG. Outcome of HIV infection in transplant patient on cyclosporin. Lancet 1991: 337: 794.
34. BOUSCARAT F, SAMUEL D, SIMON F, DEBAT P, BISMUTH H, SAIMOT AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994: 19: 854-859.
35. MCCARTHY M, GANE E, PEREIRA S, et al. Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut 1996: 39: 870-875.
36. GORDON FH, MISTRY PK, SABIN CA, LEE CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998: 42: 744-749.
37. RAGNI MV, DODSON SF, HUNT SC, BONTEMPO FA, FUNG JJ. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood 1999: 93: 1113-1114.
38. TOLAN DJ, DAVIES MH, MILLSON CE. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001: 345: 1781.
39. Gow PJ, MUTIMER D. Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy. Aids 2001: 15: 291-292.
40. STOCK PG, ROLAND ME, CARLSON L, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: A pilot safety and efficacy study. Transplantation 2003: 76: 370-375.
41. NEFF GW, BONHAM A, TZAKIS AG, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003: 9: 239-247.
42. SAMUEL D, DUCLOS VALLEE JC, TEICHER E, VITTECOQ D. Liver transplantation in patients with HIV infection. J Hepatol 2003: 39: 3-6.
43. RAGNI MV, BELLE SH, IM K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003: 188: 1412-1420.
44. ROLAND ME, STOCK PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003: 75: 425-429.
45. FREEMAN RB JR., WIESNER RH, HARPER A, et al. The new liver allocation system: Moving toward evidence-based transplantation policy. Liver Transpl 2002: 8: 851-858.
46. FISHMAN JA. Transplantation for patients infected with human immunodeficiency virus: No longer experimental but not yet routine. J Infect Dis 2003: 188: 1405-1411.
47. BURCHETT SK, PIZZO PA. HIV infection in infants, children, and adolescents. Pediatr Rev 2003: 24: 186-194.
48. RESTI M, AZZARI C, BORTOLOTTI F. Hepatitis C virus infection in children coinfected with HIV: Epidemiology and management. Paediatr Drugs 2002: 4: 571-580.
49. GIBB DM, GOODALL RL, DUNN DT, et al. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission. Lancet 2000: 356: 904-907.
50. GHANY MG, LEISSINGER C, LAGIER R, SANCHEZ-PESCADOR R, LOK AS. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996: 41: 1265-1272.
51. RIZZARDI GP, HARARI A, CAPILUPPI B, et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest 2002: 109: 681-688.
52. SUN Y, PINCHUK LM, AGY MB, CLARK EA. Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway. J Immunol 1997: 158: 512-517.
53. BILLICH A, HAMMERSCHMID F, PEICHL P, et al. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: Interference with HIV protein-cyclophilin A interactions. J Virol 1995: 69: 2451-2461.
54. CALABRESE LH, LEDERMAN MM, SPRITZLER J, et al. Placebo-controlled trial of cyclosporin-A in HIV-1 disease: Implications for solid organ transplantation. J Acquir Immune Defic Syndr 2002: 29: 356-362.
55. PANDOLFI F, PIERDOMINICI M, MARZIALI M, et al. Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART. Clin Immunol 2000: 94: 153-159.
56. MARGOLIS D, HEREDIA A, GAYWEE J, OLDACH D, DRUSANO G, REDFIELD R. Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J Acquir Immune Defic Syndr 1999: 21: 362-370.
57. CHAPUIS AG, PAOLO RIZZARDI G, D'AGOSTINO C, et al. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000: 6: 762-768.
58. CALABRESE LH, ALBRECHT M, YOUNG J, et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 2003: 348: 2323-2328.
59. Updated US Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001: 50: 1-52.
60. CARDO DM, CULVER DH, CIESIELSKI CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997: 337: 1485-1490.
61. GERBERDING JL. Clinical practice. Occupational exposure to HIV in health care settings. N Engl J Med 2003: 348: 826-833.
62. HALPERN SD, UBEL PA, CAPLAN AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002: 347: 284-287.